Affluent Medical SAS (PA:AFME) — Market Cap & Net Worth
Market Cap & Net Worth: Affluent Medical SAS (AFME)
Affluent Medical SAS (PA:AFME) has a market capitalization of $110.43 Million (€94.45 Million) as of May 4, 2026. Listed on the PA stock exchange, this France-based company holds position #18793 globally and #282 in its home market, demonstrating a 53.97% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Affluent Medical SAS's stock price €2.81 by its total outstanding shares 39297813 (39.30 Million). Analyse AFME cash flow metrics to see how efficiently the company converts income to cash.
Affluent Medical SAS Market Cap History: 2021 to 2026
Affluent Medical SAS's market capitalization history from 2021 to 2026. Data shows change from $261.42 Million to $129.10 Million (-20.17% CAGR).
Index Memberships
Affluent Medical SAS is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Health Care
FRHC
|
$262.01 Billion | 0.04% | #26 of 36 |
Weight: Affluent Medical SAS's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Affluent Medical SAS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Affluent Medical SAS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
15.06x
Affluent Medical SAS's market cap is 15.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $261.42 Million | $1.45 Million | -$14.82 Million | 180.16x | N/A |
| 2022 | $77.18 Million | $1.34 Million | -$15.23 Million | 57.64x | N/A |
| 2023 | $84.77 Million | $1.22 Million | -$15.65 Million | 69.25x | N/A |
| 2024 | $62.02 Million | $4.12 Million | -$14.74 Million | 15.06x | N/A |
Competitor Companies of AFME by Market Capitalization
Companies near Affluent Medical SAS in the global market cap rankings as of May 4, 2026.
Key companies related to Affluent Medical SAS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Affluent Medical SAS Historical Marketcap From 2021 to 2026
Between 2021 and today, Affluent Medical SAS's market cap moved from $261.42 Million to $ 129.10 Million, with a yearly change of -20.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €129.10 Million | +62.43% |
| 2025 | €79.48 Million | +28.15% |
| 2024 | €62.02 Million | -26.83% |
| 2023 | €84.77 Million | +9.82% |
| 2022 | €77.18 Million | -70.47% |
| 2021 | €261.42 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Affluent Medical SAS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $110.43 Million USD |
| MoneyControl | $110.43 Million USD |
| MarketWatch | $110.43 Million USD |
| marketcap.company | $110.43 Million USD |
| Reuters | $110.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Affluent Medical SAS
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardio… Read more